This Kaiser/CSIS forum examines the major policy, research and other developments arising from the 2010 International AIDS Conference (AIDS 2010) in Vienna, Austria.
HIV/AIDSSee more about HIV/AIDS
- state & global data
- view as grid
- view as list
There are multiple sources of insurance coverage and care for people with HIV in the United States. These include public programs, such as Medicaid and Medicare, and the Ryan White HIV/AIDS program, as well as private coverage through an employer or in the individual market. Medicaid, the nation’s principal safety-net…
Medicaid is the nation’s major public health program for low-income Americans, financing health and long-term care services. It accounts for approximately half of federal spending on HIV/AIDS care in the U.S. and is a critical source of coverage for people living with HIV/AIDS. This fact sheet provides data and information on HIV/AIDS and Medicaid eligibility, benefits, spending, caseload and future outlook.
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
This updated fact sheet highlights the epidemic’s impact on Black Americans, providing current data and trends over time. Black Americans have been disproportionately affected by HIV/AIDS since the epidemic’s beginning, and that disparity has deepened over time. Blacks account for more new HIV infections, people estimated to be living with HIV disease, and HIV-related deaths than any other racial/ethnic group in the U.S.
This session will explore how policy makers and programme managers can work with the current state of knowledge and unanswered questions about what works in HIV prevention to develop strategic, combination prevention responses.
AIDS 2012: Comprehensive HIV Prevention for People Who Use Drugs: Ways Forward for Inclusion of Needle and Syringe Exchange Programmes
This session will address the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.
This session will bring together some of these global leaders to discuss how, in their experience, public-private partnerships are an innovative way to bring together diverse organizations and target the same goal of efficient local programmes that, at the same time, translate into powerful advocacy tools at the global level.
This session will present examples of in-country ownership for developing strategies and solutions for achieving national HIV goals, drawing on the perspectives of government and business sectors.